NCT03249948

Brief Summary

Despite significant advances in resuscitation efforts, there are some patients who remain in refractory ventricular fibrillation (VF) during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED) and vector change defibrillation have been proposed as a viable option for patients in refractory VF. This pilot cluster randomized trial will compare (1) continued resuscitation using standard defibrillation; (2) resuscitation involving DSED; or (3) resuscitation involving vector change defibrillation, in patients presenting with refractory VF during out-of-hospital cardiac arrest. The results of this pilot study will provide critical data for planning a larger, adequately powered multi-site randomized controlled trial to clinically evaluate DSED and vector change defibrillation compared to standard therapy for patients in refractory VF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 15, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

March 5, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2020

Completed
Last Updated

March 18, 2020

Status Verified

March 1, 2020

Enrollment Period

1.5 years

First QC Date

August 1, 2017

Last Update Submit

March 17, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Return of spontaneous circulation (ROSC)

    Binary outcome of whether or not patient returned to spontaneous circulation

    1 day

  • Feasibility of double sequential external defibrillation

    80% or greater of patients receiving proper randomization and 80% or greater receiving an intervention shock prior to shock 6

    Day 1

Secondary Outcomes (3)

  • VF termination after first interventional shock

    1 day

  • VF termination inclusive of all interventional shocks

    1 day

  • Number of defibrillation attempts to obtain ROSC

    1 day

Study Arms (3)

Standard defibrillation

NO INTERVENTION

All defibrillation attempts will occur using the standard defibrillation method, i.e. defibrillation pads will be placed in the anterior-anterior configuration. The patient may also be administered antiarrythmic agents and epinephrine, as per current provincial standard.

Vector change defibrillation

OTHER

The first three shocks will occur with defibrillation pads placed in the anterior-anterior position. All further shocks will occur with the pads placed in the anterior-posterior position. The patient may also be administered antiarrythmic agents and epinephrine, as per current provincial standard.

Procedure: Vector change defibrillation

Double-sequential defibrillation

OTHER

The first three shocks will occur with defibrillation pads placed in the anterior-anterior position. For all further shocks, a second set of defibrillation pads (via a second on scene EMS or fire defibrillator) will be applied in the anterior-posterior position, and defibrillation will be carried out by sequential defibrillation shocks provided by the two defibrillators (i.e. with a short delay between the two defibrillators). The patient may also be administered antiarrythmic agents and epinephrine, as per current provincial standard.

Procedure: Double-sequential defibrillation

Interventions

Defibrillation using pad placement in anterior-posterior position.

Vector change defibrillation

Defibrillation using two defibrillators, one with pad placement in anterior-posterior position, and the other with pad placement in anterior-anterior position, delivering two rapid sequential shocks.

Also known as: Double sequential external defibrillation, DSED
Double-sequential defibrillation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years of age, non-traumatic cardiac arrest of presumed cardiac etiology, presenting rhythm to EMS of ventricular fibrillation; no ROSC or non VF rhythm after three consecutive EMS shocks.

You may not qualify if:

  • Traumatic cardiac arrest, patients with pre-existing do not resuscitate orders, presumed pregnancy, patients in recurrent ventricular fibrillation (defined as those with a secondary presentation of VF (not the presenting rhythm) or those presenting in VF but did not receive three consecutive defibrillation attempts).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Peel Regional Paramedic Service

Brampton, Ontario, Canada

Location

Halton Region Paramedic Services

Oakville, Ontario, Canada

Location

County of Simcoe Paramedic Services

Simcoe, Ontario, Canada

Location

Toronto Paramedic Services

Toronto, Ontario, Canada

Location

MeSH Terms

Conditions

Ventricular Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sheldon Cheskes, MD

    Sunnybrook Centre for Prehospital Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This is a cluster randomized study, with cluster units defined by EMS agency. Each cluster will crossover at three times during the one year trial so that each agency will spend 4 months in each arm of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2017

First Posted

August 15, 2017

Study Start

March 5, 2018

Primary Completion

September 10, 2019

Study Completion

March 12, 2020

Last Updated

March 18, 2020

Record last verified: 2020-03

Locations